aminophylline has been researched along with Respiratory Distress Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdollahi, M; Bahaadini, K; Hadavand, N; Moharreri, M; Mojtahedzadeh, M; Najafi, A; Sadraie, S; Salari, P | 1 |
| Nowakowski, JF | 1 |
| Howell, DE; Howell, RE; Jenkins, LP | 1 |
| Chang, ML; Chen, HI; Hsu, K; Wang, D; Wu, CP | 1 |
| Chiang, CH; Hsu, CS; Hsu, K; Huang, KL; Wang, D | 1 |
1 review(s) available for aminophylline and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Acute alveolar edema.
Topics: Acute Disease; Adrenal Cortex Hormones; Altitude Sickness; Aminophylline; Anti-Arrhythmia Agents; Capillary Permeability; Cardiotonic Agents; Diuretics; Emergencies; Fluid Therapy; Heart Failure; Heart Rate; Humans; Hydrostatic Pressure; Lung; Morphine; Myocardial Contraction; Nitroglycerin; Osmotic Pressure; Oxygen Inhalation Therapy; Posture; Pulmonary Alveoli; Pulmonary Edema; Respiration, Artificial; Respiratory Distress Syndrome | 1983 |
1 trial(s) available for aminophylline and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Comparison of the effect of aminophylline and low PEEP vs. high PEEP on EGF concentration in critically ill patients with ALI/ARDS.
Topics: Aminophylline; APACHE; Critical Illness; Epidermal Growth Factor; Female; Humans; Injections, Intravenous; Intensive Care Units; Male; Middle Aged; Outcome Assessment, Health Care; Oxygen; Partial Pressure; Patient Selection; Positive-Pressure Respiration; Respiratory Distress Syndrome; Time Factors | 2005 |
3 other study(ies) available for aminophylline and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Inhibition of lipopolysaccharide-induced pulmonary edema by isozyme-selective phosphodiesterase inhibitors in guinea pigs.
Topics: Aerosols; Aminophylline; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Dexamethasone; Disease Models, Animal; Guinea Pigs; Lipopolysaccharides; Male; Phosphodiesterase Inhibitors; Pulmonary Edema; Pyridazines; Pyrrolidinones; Respiratory Distress Syndrome; Rolipram | 1995 |
Pulmonary edema induced by phorbol myristate acetate is attenuated by compounds that increase intracellular cAMP.
Topics: Adrenergic beta-Agonists; Aminophylline; Animals; Blood Pressure; Bucladesine; Capillary Permeability; Cyclic AMP; Disease Models, Animal; Humans; Lung; Lung Injury; Male; Neutrophils; Phosphodiesterase Inhibitors; Pulmonary Artery; Pulmonary Edema; Rabbits; Respiratory Distress Syndrome; Terbutaline; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 1996 |
Dibutyryl cAMP prevents increased vascular permeability caused by air embolism in isolated rat lungs.
Topics: Aerospace Medicine; Aminophylline; Animals; Bronchodilator Agents; Bucladesine; Capillary Permeability; Drug Evaluation, Preclinical; Embolism, Air; Extravehicular Activity; In Vitro Techniques; Lung; Male; Pentoxifylline; Pulmonary Wedge Pressure; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Time Factors; Vasodilator Agents | 1997 |